Physical

Physical functioning and aging


In the table below, entries in the left column refer to the related documentation, while the values in the cells of columns LASA-B to LASA-J refer to the corresponding LASA-data files (e.g. '161' in column B refers to: 'LASAB161'). Underlined entries are hyperlinks, hovering with your mouse over the underlined waves will show you the years in which the corresponding measurements took place.

In case entries are preceeded by 'o', the corresponding files are related to the OSTEOPOR-dataset (e.g. o80 refers to 'LASAo80'). Likewise, prefixes 'g', 'z', 'zo(a)', 'zh', 'ch', and 'zd' refer to other special datasets, more information will follow.

UC: Under Construction.

More details about the LASA-waves, see LASA-introduction.

Note that some of the data are not yet available (in red).

LASA-wave  B C D E 2B F G H 3B MB I J***
Cohort 1
        xxxx       xxxx xxxx    
Cohort 2
xxxx xxxx xxxx xxxx      
Cohort 3
          xxxx xxxx xxxx    
Migrant Cohort                     xxxx xxxx
 
Blood pressure B C D E 2B F G H 3B MB I J
Blood pressure / pulse
- Blood pressure / pulse: retests
- Mean blood pressure
151
170
351
151

-
151
-
-
151
-
-
151
151

-
151
-
-
151
151

-
151
151

-
151
151

-
151
-
-
151
151

-
151
151

-
   
Body composition B C D E 2B F G H 3B MB I J
Anthropometry
- Weight and height
- Calf measurement
- Ankle, Knee and Pulse width
161
161
171
-
161
161
-
185
161
161
171
-
161
161
171
-
161
161
171
-
161
161
171
-
161
161
171
-
161
161
171
-
161
161
171
-
161
161

-
-
161
161
161

-
161
161
161

-
Weight and height history and weight changeIM 160 160 160 160 160 160 160 160 160 160 160
714
160
714
Bio-electrical impedance**
(subsample)
172 - - - - - - - - - - -
Birth weight - - - 134 134 - - - 134 - - -
Perceived body shape**
- scaled
-
-
-
-
-
-
-
-
-
-
145
345
145
345
-
-
145
345
145
345
-
-
-
-

DXA (LASA side study)
- Hip / lumbar spine scan

- Whole body scan


-
-

o41
o42

o41
o42

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-

-
-
 
Chronic diseases B C D E 2B F G H 3B MB I J
Self-report of chronic diseasesIM
- nr. of diseases reported
- tel. proxy*
- tel. respondent*
- longitudinally cleanedIM

035
235
-
-
435
035
235

602
602
435
035
235

602
702
-
035
235

602
702
-
035
235

-
-
-
035
235

602
702
-
035
235

602
702
-
035
235

602
702
-
035
235

-
-
-
035
235

-
-
-
035
235

602
702

-
035
235

602
702

-
GP information
- data
- non-response

g01
-

g01
UC

-
-

g01
g00

-
-

g01
g00

-
-

g01
g00

g01
g00

-
-

-
-

-
-
Aortic calcification (lateral radiographs) - zo22 zo22 - - - - - - - - -
Diabetes Mellitus (algorithm) zdc1 zdc1 zdc1 zdc1 zdc1
zdc2
zdc1
zdc2
zdc1
zdc2
-
-
-
-
-
-
-
-
-
-
Rheumatoid Arthritis (algorithm) - UC - - - - - - - - - -
Osteoarthritis hip and knee (algorithm) zoa1
-
-
zoa1
-
-
zoa1
-
-
zoa1-
-
-
zoa2
-
zoa1
zoa2
-
zoa1
zoa2
-
zoa1
zoa2
-
-
-
zoa3
-
-
-
zoa1
zoa2
zoa3
zoa1
zoa2
zoa3
††
Metabolic syndrome - ch02 - - - - - - - - - -
Allostatic Load (algorithm) - X - - - - - - - - - -
Cardiovascular diseases (algorithm) zh01 zh01 zh01 - - - - - - - - -
Parkinson: early P. related signs** - - - - - - - - 096 096 - -
Decubitus (bedsores) 116
159
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hyperthyroidism** - 182 182 - - - - - - - - -
Back pain - 182 182 182 - - - - - - - -
Bedridden - 182 182 - - 182 182 182 182 - - -
   
 Fertility B C D E 2B F G H 3B MB I J
Fertility (women) 119 1811 - - 181 - - - 181 181 - -
   
Falling B C D E 2B F G H 3B MB I J
Falls
- tel. proxy*
- tel. respondent*
- Falls last year

-
-
-

605
605
187

605

705
187

-
-
-

-
-
-

-
-
-

-
-
-

-
-
-

-
-
187

-
-
187

-
-
-

-
-
187
Falls: circumstances and consequences - - 187 - - - - - - - - -
Falls: environmental conditions (home)** - 180 180 - - - - - - - - -
Falls: fear of falling
(FES: Falls Efficacy Scale)
- 183 183 - - - - - - - - -
Falls: prevention of fall accidents
(LASA side study)
- - X -
- -
-
-
-
-
- -
Falls: 3 yr prospective fall calendar (LASA side study) - X - - - - - - - - - -
Falls: 1 yr prospective fall calendar (LASA side study) - - - - - - X - - - - -
DizzinessIM - 187 187 - 187 187 187 187 187 - 187 187
Adjustments and walking aids** - - 187 187 187 187 187 187 187 - - -
Foot problems - 185 185 185 - 185 - - - - - -
   
Fractures B C D E 2B F G H 3B MB I J
Fractures

- total waves b-f
- per wave

- tel. proxy*

- tel. respondent*


zo13
-

-

-


zo13
186

605

605


zo13
186

605

705


zo13
186

605

705


zo13
186

-

-


zo13
186

605

705


-
186

605

705


-
186

605

705


-
186

-

-


-
186

-

-


-
186

605

705


-
186

605

705

Vertebral deformities - zo22 zo22 - - - - - - - - -
Quantitative ultrasound of bone - o31 - - - - o31 - - - - -
 
Frailty B C D E 2B F G H 3B MB I J
Various definitions (e.g., frailty phenotype, frailty index)
X X
 
X
 
X
 
X
 

 
X
 
X X X X  
 
Lifestyle B C D E 2B F G H 3B MB I J
Alcohol useIM 153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353
153
353

Diet and food consumption

 


Lifestyle study
(LASA side study)

 

Nutrition and Food-related Behaviour   (LASA side study) with subtopics:

118
-

-
118
184

-
118
184

-
-
-

-
-
-

-
-
-

X
-
-

-
118
-

-
-
-

-
-
-

-
118
-

-
118
-

-
Oral health - - - - - X2 - - - - 126 126
Physical activityIM 046 046 046 046 046 046 046 046 046 046 046 046
Early life physical activity - 246 - - - - - - - - - -
Perceived physical activity (LIVAS)
- scaled
114

314
114

314
114

314
114

314
114

314
114

314
-

-
-

-
-

-
-

-
-

-
-

-

Accelerometry (side studies)

- subsample (Study 1)
- subsample (Study 2)

- subsample (Study 3)

- subsample (Study 4)

 

-
-

-
-

 

-
-

-
-

 

-
-

-
-

 

-
-

-
-

 

-
-

-
-

 

X2
-

-
-

 

-
X

-
-

 

-
-

X
-

 

-
-

-
-

 

-
-

-
-

 

-
-

-
X

 
Sedentary behavior
- scaled
- scaled
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
101
301
501
101
301

-
101
301

-
101
301

-
101
301

-
101
301

-
SmokingIM 154 154 154 154 154 154 154 154 154 154 154 154
   
Medication/supplements B C D E 2B F G H 3B MB I4 J

Medication and food supplement use
- types of medication

152
352

152
352
152
352
152
352
152
352
152
352
152
352
152
352
152
352
152
352
152
352
152
352
Food supplement use
Vitamin D use included
- - - - - - - - - - 174 374 174 374
 
Mortality
B C D E 2B F G H 3B MB I J
Mortality data
see Demographics
 
Cause of death z990
z991
z992
z990
z991
z992
z990
z991
z992
z990
z991
z992
z990
z991
z992
z990
z991
z992
z990
-
-
z990
-
-
z990
-
-
-
-
-
z990
-
-
 
   
Pain B C D E 2B F G H 3B MB I J
Subjective painIM
- scaled
115
315
115
315
115
315
115
315
115
315
115
315
115
315
115
315
115
315
115
315
115
315
115
315
Dealing with pain** - - - 188 - - - - - - - -
Pain drawing - - - 188 - - - - - - - -
   
Perception B C D E 2B F G H 3B MB I J

Vision (self-report)IM
- total scores

- tel. proxy*

- tel. respondent*

031
231

-

-

031
231

604

604

031
231

604

704

031
231

604

704

031
231

-

-

031
231

604

704

031
231

604

704

031
231

604

704

031
231

-

-

031
231

-

-

031
231

604

704

031
231

604

704

Visual acuity test
Vision-related quality of life

-
-
-
-
-
-
191
192
-
-
191
192
191
192
191
192
191
-
-
-
-
-
 
Vision: contrast sensitivity 157 157 157 157 157 157 - - - - -  
   

Hearing (self-report)IM
- total scores

- tel. proxy*

- tel. respondent*

031
231

-

-

031
231

604

604

031
231

604

704

031
231

604

704

031
231

-

-

031
231

604

704

031
231

604

704

031
231

604

704

031
231

-

-

031
231

-

-

031
231

604

704

031
231

604

704

Hearing: Speech in Noise Test (SNT)
Hearing: SNT questions
-
-
-
-
-
-
193
194
-
-
193
194
193
194
-
-
-
-
-
-
PM
PM
-
-
 
Smell (Olfactory function) - - - - - - - - S00
S01
S02
S00
S01
S02

- -
   
Physical functioning B C D E 2B F G H 3B MB I J

Functional limitations/Disability (ADL)IM
- constructed
- use of assistive devices or assistance

- tel. proxy*
- tel. respondent*
- Limitations in joint mobility

030
230
030

-
-
-

030
230
030

603
603
183

030
230
030

603
703
183

030
230
030

603
703
183

030
230
030

-
-
-

030
230
030

603
703
-

030
230
030

603
703
-

030
230
030

603
703
-

030
230
030

-
-
-

030
230
030

-
-
-

030
230
030

603
703
-

030
230
030

603
703
-

Global Activitity Limitations
- tel. respondent*
033
-
033
603
033
703
033
703
033
-
033
703
033
703
033
703
033
-
-
-
033
703
033
703
Physical performance
034 034 034 034 034 034 034 034 034 034 034 034

Pulmonary function test

- Peak Flow
- Spirometry (post bronchodilator)

-
158

-

-
158

-

-
158

-

-
158

-

-
-

-

-
-

-

-
158

-

-
158

-

-
-

168

-
-

-

-
-

-

-
-

-

Grip strength - 161 161 161 161 161 161 161 161 161 161 161
 
Quality of life B C D E 2B F G H 3B MB I J
EuroQol
- scaled
-
-
-
-
-
-
135
335
-
-
135
335
135
335
135
335
135
335
-
-
135
335
-
-
Qualeffo-41
- (non)response
- Qualeffo scores
- scaled


-
-
-


-
-
-


-
-
-


o80
o81
o82


-
-
-


-
-
-


-
-
-


-
-
-


-
-
-


-
-
-


-
-
-


-
-
-

SF-12 Health Survey
- scaled

- scaled (Am.)

-
-

-

-
-

-

133
333

533

133
333

533

-
-

-

133
333

533

133
333

533

133
333

533

133
333

533

-
-

-

133
333

533

133
333

533

WHO Quality of Life** - - - - - - - - - - 133 133
Self-rated health
- GHPQ
- GHPQ: scaled
- tel. proxy*
- tel. respondent*
036
113
313

-
-
036
113
313

602
602
036
113
313

602
702
036
113
313

602
702
036
113
313

-
-
036
113
313

602
702
036
113
313

602
702
036
113
313

602
702
036
113
313

-
-
036
-
-
-
-
036
-
-
602
702
036
-
-

602
702
   
LASA-wave  B C D E 2B F G H 3B MB I J***


* Files in the 700 series contain data from telephone interviews held with respondents, while files in the 600 series contain data from telephone interviews held with proxies. In wave C however, the same questionnaire was used for both respondent and proxy; data was stored in the 600 series.

** Not yet documented

*** Under construnction

 

1 Fertility (Women) moved from self-administered questionnaire (LASAB119) to medical interview (LASAC181 / LAS2B181 / LAS3B181 / LASMB181)

 

2 As part of the Lifestyle study

 

3 As part of the EPOSA study


4 In wave I Food supplement questions moved to LASA174

IM In 2004, three years after wave E an interim measurement was carried out on the first cohort, see the specific topics for more details. More information will follow.